Bioscript Limited
- Company number
- 13216692
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 22 Feb 2021
- Nature of business
- Activities of other holding companies n.e.c.
- Corporate group
- Bioscript Midco 2 Limited (14 companies)
Registered office
Previous names
- Libretto Bidco Limited (until 29 Oct 2021)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DALLI, Dominic Stefan | Director | 22 Feb 2021 | 29 Mar 2021 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Bioscript Midco 2 Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
22 Feb 2021 |
Accounts
| Year ended | Turnover | Net assets | Cash | Employees |
|---|---|---|---|---|
| 30 Sep 2025 | - | - | - | - |
| 30 Sep 2024 | £1,142,823 | -£26,334,912 | £41,086 | 13 |
| 30 Sep 2023 | £1,275,418 | -£17,950,093 | £3,577 | 11 |
| 30 Sep 2022 | £956,677 | £3,574,240 | £1,102,204 | 7 |
| 30 Sep 2021 | £408,237 | £3,864,411 | - | 7 |
Connections
Owned by
Bioscript Limited → Bioscript Midco 2 Limited
Controls
- Azimuth Pharma Limited (07916512)
- Bioscript Group Limited (09542360)
- Enzyme Communications Ltd (10790509)
- Meridian Healthcomms Holdings Limited (11350918)
- Triducive Partners Limited (11863552)
- Valid Insight Ltd (08539682)
Companies at the same address
- Azimuth Pharma Limited (07916512)
- Bioscript Group Limited (09542360)
- Bioscript Holdings Limited (13203898)
- Bioscript Midco 1 Limited (13208513)
- Bioscript Midco 2 Limited (13212966)
- Bioscript Stirling Limited (04354625)
- Cancer Communications And Consultancy Limited (05049252)
- Enzyme Communications Ltd (10790509)
- Fortis Pharma Consulting Limited (05390470)
- Medologie Limited (09432933)